• Home
  • Contact Us
  • Sitemap
  • About Aveo
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Careers
  • Product Candidates
    • Overview
    • Tivozanib (AV-951)
    • Ficlatuzumab (AV-299)
    • AV-203
    • For Physicians
    • For Patients
  • Discovery Programs
    • Overview
    • FGF Program
    • Notch Program
    • RON Program
  • Our Platform
    • Platform Overview
  • Partnering
    • Our Approach
    • Our Partners
    • Areas of Interest
  • Partnering
  • Our Approach
  • Our Partners
  • Areas of Interest
 

Partnering

Importance of Collaborations at AVEO

AVEO is committed to discovering, developing and commercializing targeted therapies to impact patients’ lives. To support these efforts, we continue to evaluate opportunities to collaborate with other pharmaceutical and biotechnology companies that share AVEO’s vision for oncology drug development. Importantly, as AVEO continues to build its commercial infrastructure, we seek collaborations that align with our strategic, long-term corporate goals.

 

AVEO has entered into multiple strategic partnerships. If you would like more information on current partnering opportunities with AVEO, we invite you to read more about our specific areas of interest or contact aveobd@aveopharma.com.   

 

AVEO Pipeline

 
 

© 2010 AVEO Pharmaceuticals, Inc. All rights reserved.

  • Home
  • Contact Us
  • Sitemap
  • Terms
  • Privacy
  •   |  
  • Investors
  • Careers